首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Comparative Study between Liquisolid Compacts, Liquisolid Microsystem and Solid Dispersion Technology for the Preparation of Immediate Release Nicardipine Tablets
【24h】

Comparative Study between Liquisolid Compacts, Liquisolid Microsystem and Solid Dispersion Technology for the Preparation of Immediate Release Nicardipine Tablets

机译:Liquisolid压块,Liquisolid微系统和固体分散技术制备速释尼卡地平片的比较研究

获取原文
       

摘要

Liquisolid technology is a new concept for drug delivery that can improve dissolution of poorly soluble drugs. Nicardipine is class ll drug had low bioavailability mainly due to its poor dissolution. In this work, immediate release tablets of nicardipine had been prepared using liquisolid (F1-F11), liquisolid microsystem (MSF1-MSF6 and MSF10) and solid dispersion (SD1-SD6) technologies then comparing their pre-compression, post-compression and in-vitro dissolution profiles, in addition to X-ray, DSC and SEM analysis. It was found that optimum liquisolid formula (F10) and liquisolid microsystem (MSF3) showed significantly higher flowability, compressibility parameters and higher dissolution rate than solid dispersion formula (SD2) since the drug is in the solubilized form and completely in the amorphous state which provides greater surface area for drug dissolution. While the lowest dissolution rate was for the formula prepared by direct compression method and the marketed tablet. This study also showed that liquisolid microsystem compacts showed increase in drug loading capacity due to the presence of PVP and reducing the amount of additives significantly thus reducing the total weight of the tablet to more than half which improve patients compliance and economic feasibility.
机译:Liquisolid技术是药物输送的新概念,可以改善难溶性药物的溶出度。尼卡地平是II类药物,具有较低的生物利用度,这主要是由于其溶解性差。在这项工作中,尼卡地平速释片的制备方法是使用liquisolid(F1-F11),liquisolid微系统(MSF1-MSF6和MSF10)和固体分散体(SD1-SD6)技术,然后比较它们的压缩前,压缩后和除X射线,DSC和SEM分析外,还具有体外溶出曲线。已发现,与药物分散体形式(SD2)相比,最佳的液体固体配方(F10)和液体固体微系统(MSF3)表现出明显更高的流动性,可压缩性参数和更高的溶出速率,因为该药物处于增溶形式且完全处于无定形状态,从而提供了更大的药物溶解表面积。而最低溶出率是通过直接压片法和市售片剂制备的配方。这项研究还表明,由于PVP的存在,liquisolid微系统粉盒显示出药物载量的增加,并显着减少了添加剂的量,从而将片剂的总重量减少了一半以上,从而提高了患者的依从性和经济可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号